Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

LESSONS LEARNED: Trials focusing on unresectable multifocal glioblastoma are needed because of the extremely poor prognosis and challenges in receiving standard therapy, such as concurrent radiation and chemotherapy. Developing a strategy to chemically debulk tumors before radiation and/or surgery i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Peters, Katherine B., Lou, Emil, Desjardins, Annick, Reardon, David A., Lipp, Eric S., Miller, Elizabeth, Herndon, James E., McSherry, Frances, Friedman, Henry S., Vredenburgh, James J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2015
Soggetti:
Clinical Trial Results
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492239/
https://ncbi.nlm.nih.gov/pubmed/26025933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0135
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi